Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.12, 1998-12, pp. : 1759-1761
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dental Enamel Structure Is Altered by Expression of Dominant Negative RhoA in Ameloblasts
Cells Tissues Organs, Vol. 194, Iss. 2-4, 2011-05 ,pp. :
Access to resources
Recommend
By Kocarek T.A. Shenoy S.D. Mercer-Haines N.A. Runge-Morris M.
Journal of Pharmacological and Toxicological Methods, Vol. 47, Iss. 3, 2002-05 ,pp. :
Solifenacin economically dominant in OAB
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Agomelatine dominant for MDD in Turkey . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :
Solifenacin economically dominant in OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. :